Join STAT Brand Studio and Quanterix for this virtual event to explore the transformative role of blood biomarkers in dementia research and clinical care. Hear from industry expert:
From global proteomics to disease-specific markers like p-Tau 217, GFAP, and amyloid-beta, we'll explore their impact on Alzheimer's and other neurodegenerative diseases. The session will spotlight plasma p-Tau 217's utility and discuss future possibilities, such as remote testing and emerging markers.
Don't miss the opportunity to learn about the pivotal role of blood biomarkers in enhancing dementia diagnosis and treatment.
%20MH%20Testing/Larger%20Header%20Logos/STAT_BrandStudio2.png?height=88&upscale=true&name=STAT_BrandStudio2.png){kind=small}
.jpg?noresize&width=560&upscale=true&name=SBS_Samsung_CalendarImage%20(1).jpg)
No comments